CarelabsLtd Balance Sheet Health
Financial Health criteria checks 5/6
CarelabsLtd has a total shareholder equity of ₩77.7B and total debt of ₩47.7B, which brings its debt-to-equity ratio to 61.4%. Its total assets and total liabilities are ₩153.9B and ₩76.2B respectively.
Key information
61.4%
Debt to equity ratio
₩47.68b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩28.36b |
| Equity | ₩77.68b |
| Total liabilities | ₩76.21b |
| Total assets | ₩153.89b |
Recent financial health updates
Recent updates
There Is A Reason Carelabs Co.,Ltd's (KOSDAQ:263700) Price Is Undemanding
Nov 12
The Market Doesn't Like What It Sees From Carelabs Co.,Ltd's (KOSDAQ:263700) Revenues Yet
Aug 07We Think CarelabsLtd (KOSDAQ:263700) Has A Fair Chunk Of Debt
Jun 12Carelabs Co.,Ltd (KOSDAQ:263700) Held Back By Insufficient Growth Even After Shares Climb 50%
Feb 27Financial Position Analysis
Short Term Liabilities: A263700's short term assets (₩39.2B) do not cover its short term liabilities (₩45.2B).
Long Term Liabilities: A263700's short term assets (₩39.2B) exceed its long term liabilities (₩31.1B).
Debt to Equity History and Analysis
Debt Level: A263700's net debt to equity ratio (24.9%) is considered satisfactory.
Reducing Debt: A263700's debt to equity ratio has reduced from 74.6% to 61.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A263700 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A263700 has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 22.8% each year.